BioPhausia AB - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for BioPhausia AB. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

BioPhausia AB. The Group's principal activity is the marketing and sale of pharmaceuticals through licensing agreements with other pharmaceutical companies and through parallel imports. The Group operates on the Nordic market. In 2006 the Group acquired a product line comprising of 17 pharmaceuticals from AstraZeneca. In 2006 the Group moved into the field of veterinarian pharmaceuticals. The Group acquired All-Gen in 2007.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report